Meta Health Limited

Meta Health Limited

SSGX:5DX
0.00
SGD
+0.00
(-33.33%)
0.00EPS
5.28MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.15
0.15
0.11
0.11
0.12
0.1
0.1
0.07
0.08
0.02
0.01
- -
- -
- -
Basic EPS, GAAP
- -
-0.01
- -
-0.01
-0.02
-0.01
- -
- -
- -
-0.02
-0.01
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
0.01
- -
-0.01
-0.01
0.01
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.06
0.06
0.06
0.05
0.04
0.03
0.04
0.03
0.02
0.01
- -
- -
- -
- -
Tangible Book Value per Share
0.06
0.06
0.05
0.05
0.04
0.03
0.04
0.03
0.02
0.01
- -
- -
- -
- -
Basic Weighted Avg Shares
458
463
472
472
472
472
472
472
523
571
697
1,057
1,309
1,320
Sales/Revenue/Turnover
69
69
52
53
56
47
45
32
43
11
5
- -
1
1
Operating Margin (%)
1.76
-4.28
1.92
-3.59
-10.31
-9.97
1.65
-4.97
-0.09
-42.63
-61.06
-626.49
-86.04
-60.28
Depreciation Expense
4
4
3
4
3
3
3
3
3
3
2
- -
- -
- -
Net Income, GAAP
- -
-3
1
-3
-9
-5
- -
-2
1
-9
-8
-1
-1
- -
Effective Tax Rate (%)
38.46
- -
3.17
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
0.49
-4.1
1.02
-5.66
-15.7
-11.71
0.44
-6.08
2.7
-76.02
-182.25
-588.5
-91.8
-64.44
Working Capital
10
10
10
9
3
-2
-3
10
9
1
1
-2
-2
-2
LT Debt
1
1
1
1
1
1
2
5
5
4
2
- -
- -
- -
Total Equity
29
27
27
24
21
15
17
15
16
5
- -
-2
-1
-2
Return on Invested Capital (%)
1.91
- -
2.11
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
1.62
- -
2.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
1.18
-10.15
1.98
-11.8
-39.18
-30.28
1.26
-12.19
7.41
-82.24
- -
- -
- -
- -

Capital Structure

SGD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,320
1,320
1,320
Market Capitalization
5
5
5

Working Capital

SGD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
3
4
Payables & Accruals
- -
- -
- -
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.47%
11.05%
-12.76%
Free Cash Flow
150.43%
589.87%
-13.78%
Net Income, GAAP
-278.5%
-220.86%
-13.35%
Sales/Revenue/Turnover
21.99%
52.25%
455.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

SGD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Sector
Producer manufacturing
Industry
Miscellaneous manufacturing
Address
Singapore Singapore
IPO Date
Dec 15, 2003
Business
Meta Health Limited, an investment holding company founded in 1987 and headquartered in Singapore, provides healthcare and digital health services, medical supplies distribution, and precision engineering manufacturing solutions. The company operates through two primary business divisions: Healthcare and Precision Engineering. Within its Healthcare division, primarily conducted through its subsidiary Gainhealth Pte. Ltd., the company provides virtual care and telemedicine consultations; primary care and occupational healthcare services through physical medical clinics; mobile medicine and home healthcare services; retail and online direct-to-consumer pharmacy fulfillment; wholesale supply and distribution of pharmaceutical products, medical equipment, and over-the-counter health supplements; and clinical management and digital health platform integration solutions. Within its Precision Engineering division, the company manufactures and sells customized precision metal stamped parts; precision sheet metal fabrication components; mechanical assemblies and sub-assemblies; precision tooling, fixtures, and stamping dies; and surface finishing and electro-galvanized coating treatments, serving multinational original equipment manufacturers and electronic manufacturing services providers across the automotive, industrial machinery, telecommunications, consumer electronics, and medical device industries. The company operates corporate offices, medical facilities, and manufacturing plants across Singapore, Malaysia, Thailand, and China. In recent strategic developments, the company executed a major corporate transformation from a traditional manufacturing enterprise into a diversified healthcare and technology provider, marked by its official name change from Metal Component Engineering Limited to Meta Health Limited. To accelerate this transition, the company acquired omnichannel health platform Gainhealth Pte. Ltd., expanded its regional cross-border telemedicine capabilities, formed digital health partnerships across Southeast Asia, and reorganized its precision engineering division to optimize operational efficiencies and target specialized medical hardware manufacturing.